VIVUS, Inc. VVUS recently announced an agreement with Sanofi SNY to reacquire the commercial rights to its erectile dysfunction drug, Stendra (avanafil), in Africa, the Middle East, Turkey and the ...
Apart from obesity drug Qsymia, VIVUS, Inc.’s (VVUS) portfolio consists of another approved product, Stendra (trade name: Spedra in Europe), for erectile dysfunction (ED). Stendra, a phosphodiesterase ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - The erectile dysfunction drug Stendra, currently approved by the U.S. Food and Drug Administration for use 30 minutes ...
The erectile dysfunction drug Stendra, currently approved by the U.S. Food and Drug Administration for use 30 minutes before sex, has now been approved for use as little as 15 minutes before sex, the ...
The FDA announced that it has approved Stendra (avanafil; Vivus Inc.) tablets for the treatment of erectile dysfunction. Stendra’s safety and efficacy were established in three double-blind, ...
Vivus and Auxilium announced that the Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Stendra (avanafil) to be taken ~15 minutes before sexual activity ...
Erectile dysfunction affects an estimated 30 million in the U.S., according to the National Institutes of Health. That works out to nearly one in 10 men. A variety of treatments exist for this common ...
MOUNTAIN VIEW, CA and CHESTERBROOK, PA--(Marketwired - September 18, 2014) - VIVUS, Inc. (VVUS) and Auxilium Pharmaceuticals, Inc. (AUXL) today announced that the U.S. Food and Drug Administration ...
Over the last 25 years, (ED) medications like Viagra and Cialis have become common fixtures in bedrooms around the world. These little pills have helped hundreds of millions of men get hard and stay ...
(CBS News) A new erectile dysfunction drug that reportedly works in less than 15 minutes has just received approval from the U.S. Food and Drug Administration. On Friday the FDA approved Vivus Inc.'s ...
Last Friday, the Federal Drug Administration (FDA) approved a new erectile dysfunction drug, Stendra, which its creators are touting as a superior alternative to Viagra. Erectile dysfunction, or the ...
Touting an off-label use is a big no-no when it comes to pharma marketing, and that's exactly what's landed Metuchen Pharmaceuticals in trouble with the FDA's promo police. The agency's Office of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results